Holen Sie sich die Stockscreener-App
7.30
0.00%
0.00
Kamada Ltd Aktie (KMDA) Neueste Nachrichten
How to recover losses in Kamada Ltd. stockJuly 2025 Summary & Free Long-Term Investment Growth Plans - Newser
Will Kamada Ltd. rebound enough to break evenWeekly Trade Review & Smart Investment Allocation Tips - Newser
Kamada Ltd. Reports Strong Financial Results and FDA Approval in August 2025 - MSN
Is Kamada Ltd. still worth holding after the dipRisk Management & Daily Profit Maximizing Tips - Newser
Kamada Ltd. Achieves 11% Revenue Growth, Raises EBITDA Guidance - AInvest
Kamada stock price target maintained at $15 by Benchmark on strong earnings - Investing.com
Kamada Ltd. (NASDAQ:KMDA) Q2 2025 Earnings Call Transcript - Insider Monkey
Using RSI to spot recovery in Kamada Ltd.2025 Stock Rankings & Community Trade Idea Sharing Platform - Newser
How hedge fund analytics apply to Kamada Ltd. stockInsider Selling & Weekly Chart Analysis and Guides - Newser
How sentiment analysis helps forecast Kamada Ltd.July 2025 Volume & Free Community Consensus Stock Picks - Newser
Momentum Traders Eye Kamada Ltd. for Quick BounceJuly 2025 Earnings & Real-Time Chart Breakout Alerts - beatles.ru
Kamada Ltd (KMDA) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Increased ... - Yahoo Finance
Kamada Ltd. Reports Strong 2025 Financial Growth - TipRanks
Kamada's Q2 2025: Tax Rate Fluctuations and Clinical Enrollment Contradictions Unveiled - AInvest
Kamada Q2 2025 Earnings Call Transcript - MarketBeat
Kamada Reports Strong Q2 Earnings, Raises Full-Year Guidance, and Secures FDA Approval for Plasma Collection Center - AInvest
Kamada Ltd Outpaces Expectations As FDA Nod Adds Fuel - Finimize
Kamada Ltd Outpaces Expectations With Strong Results And Upbeat Forecast - Finimize
Kamada Ltd reports results for the quarter ended June 30Earnings Summary - TradingView
Kamada: Q2 Earnings Snapshot - Connecticut Post
Kamada's Q2 Earnings and Strategic Growth Catalysts: A Deep Dive into a Biopharma Innovator's Scalable Model - AInvest
Will breakout in Kamada Ltd. lead to full recoveryMarket Volume Report & Weekly High Momentum Picks - Newser
Kamada Reports Strong Second Quarter and First Half 2025 - GlobeNewswire
Kamada Reports Q2 Earnings: EPS Beats Expectations, Revenue Misses - AInvest
Kamada Raises Full-Year Guidance as Plasma Therapy Sales Drive 35% Profit Growth - Stock Titan
Strategies to average down on Kamada Ltd.2025 Short Interest & Long-Term Safe Investment Plans - Newser
Kamada Receives FDA Approval for Houston Plasma Center - AInvest
Kamada’s Houston Plasma Center Gains FDA Approval - The Globe and Mail
Can Kamada Ltd. deliver alphaMulti-Year Breakout Candidates - metrotimes.co.kr
What makes Kamada Ltd. stock price move sharplyWeekly Stock Market Strategy Summary - Newser
Is Kamada Ltd. showing insider buyingRecession Proof Stock Watch - newsimpact.co.kr
Kamada Ltd. shares fall 2.45% after-hours as Houston Center begins sales of Normal Source Plasma. - AInvest
Kamada Says Houston Center Cleared to Begin Sales of Normal Source Plasma - MarketScreener
FDA approves Kamada’s Houston plasma collection center - Investing.com
Kamada Announces FDA Approval of its Plasma Collection Center in Houston, Texas - GlobeNewswire
Kamada Secures FDA Approval for $10M Revenue Plasma Center, Set to Be Largest Specialty Collection Site - Stock Titan
Intrinsic Value of Kamada Ltd. Stock: Is It Undervalued or OvervaluedFree Daily Volume Spike Trading Signals - Newser
Kamada (KMDA) Expected to Announce Earnings on Wednesday - Defense World
Screener Results Flag Kamada Ltd. as OversoldWealth Building Stock Market Ideas Based on Momentum - metal.it
What recovery options are there for Kamada Ltd.Free Pattern Detection for Entry Confirmation - Newser
Is Kamada Ltd. a top pick in the sectorCompounding Growth Ideas - kangso.co.kr
Exploring Analyst Estimates for Kamada (KMDA) Q2 Earnings, Beyond Revenue and EPS - Yahoo Finance
Full technical analysis of Kamada Ltd. stockProfitable Trading Blueprint with Entry Zones - Newser
Kamada Announces Q2 and H1 2025 Financial Results on August 13, 2025. - AInvest
Kamada to Announce Q2 and H1 2025 Financial Results on August 13, 2025 - AInvest
Kamada to Announce Second Quarter and First Half Ended June 30, 2025 Financial Results on August 13, 2025 - 富途牛牛
Kamada Q2 Earnings: Rare Disease Biotech Giant Reveals Latest Financial Results Next Week - Stock Titan
Alpha-1 Antitrypsin Deficiency Pipeline Assessment Report - openPR.com
3.01%
0.28%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):